CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis

Zhonghua Wu,Bicheng Qu,Minxian Yuan,Jingjing Liu,Cen Zhou,Mingwei Sun,Zhexu Guo,Yaqing Zhang,Yongxi Song,Zhenning Wang
DOI: https://doi.org/10.1002/advs.202303246
IF: 15.1
2023-07-08
Advanced Science
Abstract:Cysteine‐rich intestinal protein‐1 (CRIP1) can interact with the cAMP responsive element binding protein 1 (CREB1) and enhance CREB1‐mediated VEGFC and CCL5 transcription. Secretion of VEGFC can induce lymphangiogenesis, while increased CCL5 in tumor microenvironment can form a concentration gradient to recruit M2 TAM, then promote TNF‐α secretion to increase lymphatic permeability. Through the reciprocal effects of VEGFC and CCL5, CRIP1 can promote lymphangiogenesis and lymphatic metastasis development in gastric cancer. Lymphangiogenesis in tumors provides an auxiliary route for cancer cell invasion to drainage lymph nodes, facilitating the development of lymphatic metastasis (LM). However, the mechanisms governing tumor lymphangiogenesis and lymphatic permeability in gastric cancer (GC) remain largely unknown. Here, the unprecedented role and mechanism of cysteine‐rich intestinal protein‐1 (CRIP1) in mediating the development of GC LM is uncovered. A series of assays are performed to identify downstream targets of CRIP1, and rescue experiments are performed to confirm the effects of this regulatory axis on LM. CRIP1 overexpression facilitates LM in GC by promoting lymphangiogenesis and lymphatic vessel permeability. CRIP1 promotes phosphorylation of cAMP responsive element binding protein 1(CREB1), which then mediates vascular endothelial growth factor C (VEGFC) expression necessary for CRIP1‐induced lymphangiogenesis and transcriptionally promotes C‐C motif chemokine ligand 5 (CCL5) expression. CCL5 recruits macrophages to promote tumor necrosis factor alpha (TNF‐α) secretion, eventually enhancing lymphatic permeability. The study highlights CRIP1 regulates the tumor microenvironment to promote lymphangiogenesis and LM in GC. Considering the current limited understanding of LM development in GC, these pathways provide potential targets for future therapeutics.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?